SCHEMBL2840856

SCHEMBL2840856

CCCCCCCCCCCCCCCCOC(CO)COCC(O)CO

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.71
HTT P42858 1/20 0.50
ALDH1A1 P00352 1/20 0.49
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
LPAR1 Q92633 5/20 0.46
LPAR3 Q9UBY5 5/20 0.46
LPAR2 Q9HBW0 2/20 0.46
KDM4E B2RXH2 1/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.46
DNM1 Q05193 1/20 0.46
LPAR5 Q9H1C0 2/20 0.44
PLA2G2C Q5R387 1/20 0.43
LPAR6 P43657 1/20 0.43
LPAR4 Q99677 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2347220 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2354120 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2345876 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL3325348 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2347679 0.98 USP2 (0.68) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2348818 0.93 USP2 (0.59) USP2HTTALDH1A1CNR1CNR2
SCHEMBL9813387 0.92 USP2 (0.69) USP2HTTALDH1A1CNR1CNR2
SCHEMBL10420319 0.92 USP2 (0.80) USP2HTTLPAR1LPAR3LPAR2
SCHEMBL28686330 0.91 CNR1 (0.64) USP2ALDH1A1CNR1CNR2LPAR1
SCHEMBL9189445 0.91 CNR2 (0.56) USP2HTTALDH1A1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522114-B1 Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin UNIVERSITY OF SOUTH FLORIDA (US) 2016-12-20 US claimed
US-20100068264-A1 NIOSOME-HYDROGEL DRUG DELIVERY SYSTEM UNIVERSITY OF SOUTH FLORIDA (US) 2010-03-18 US claimed
EP-4376864-A1 THERAPEUTIC FORMULATIONS FROM PELARGONIUM SP. AND METHOD OF USE IN RESPIRATORY VIRAL INFECTIONS Subhadra, Bobban (US) 2024-06-05 EP disclosed
WO-2023009976-A1 THERAPEUTIC FORMULATIONS FROM PELARGONIUM SP. AND METHOD OF USE IN RESPIRATORY VIRAL INFECTIONS SUBHADRA BOBBAN (US) 2023-02-02 WO disclosed
US-9522114-B1 Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin UNIVERSITY OF SOUTH FLORIDA (US) 2016-12-20 US disclosed
US-20100260830-A1 Liposomal Formulations of Tocopheryl Amides SALVATORE BRIAN A 2010-10-14 US disclosed
WO-2010118200-A2 LIPOSOMAL FORMULATIONS OF TOCOPHERYL AMIDES SALVATORE BRIAN (US) 2010-10-14 WO disclosed
US-20100068264-A1 NIOSOME-HYDROGEL DRUG DELIVERY SYSTEM UNIVERSITY OF SOUTH FLORIDA (US) 2010-03-18 US disclosed
WO-2004014152-A1 MULTI-PHASE DELIVERY SYSTEM COMPRISING A SEMI-SOLID MATRIX PHASE VITALSTATE CANADA LTD. (CA) 2004-02-19 WO disclosed
WO-2004009053-A2 ORAL DELIVERY SYSTEM CONTAINING A GEL MATRIX AND LIPOSOMES VITALSTATE CANADA LTD. (CA) 2004-01-29 WO disclosed
EP-1192920-A1 Comfortable foam-based ear plugs The Procter & Gamble Company (US) 2002-04-03 EP disclosed